Click here to see a list of our past events.
The National Cancer Institute (NCI) and the American Cancer Society (ACS) invite entrepreneurs developing cancer technologies to improve women's health to discuss the journey with the women leaders in the area! Panelists include NCI Director Dr. Kimryn Rathmell and VP of ACS extramural research Dr. Christina Annunziata, as well as women CEOs that are making an impact in the area.
This is a hybrid event, to be held at Portal Innovations Southline. Please select your preferred participation (in-person or online) in the attendance application.
Event Agenda
2:30-3:00 p.m. - Introduction and opening comments
3:00-4:00 p.m. - Fireside Chat with NCI Director, Dr. Kimryn Rathmell and Christina Annunziata, MD, PhD, Senior Vice President, Extramural Discovery Science at American Cancer Society
4:15-5:15 p.m. - Panel Discussion on Advancing Technology Development for Women’s Health (panelists below)
- Dawn Mattoon, Ph.D., CEO, Mercy BioAnalytics
- Anu Parvatiyar, Co-founder CEO, Ananya Health
- Maria Luisa Pineda, Ph.D., Co-founder & CEO, Envisagenics
- Eve McDavid, CEO & Co-founder, Mission-Driven Tech
- Shadi Saberi, Ph.D., Founder & CTO, iSono Health
- Kristin Sherman, CEO, Kovina Therapeutics
5:30-7:30 p.m. Portal Pours Networking Reception
Join Osage University Partners for a session where academic founders and partner technology transfer officers can ask managing partners Marc Singer and Bill Harrington anything and everything as it pertains to venture capital operations, decision-making and the current investing environment.
Since the purpose of this webinar is to answer your questions on venture capital and startups, submit your questions early. Query areas could include:
- Considering the fundraising environment, recommendations on how to stand out amongst the crowd
- The industry areas that are particularly interesting to VCs right now
- The best ways to get introductions to VCs
- Recommendations for first-time academic founders
Marc and Bill will also take questions from the audience the day of the webinar but sending your questions in advance will put them at the top of the queue. Register now.
Are you an academic trainee (Postdoc/PhD/MBA/MD/JD/MS) interested in building a biotech startup? Are you passionate about therapeutics, diagnostics, medtech, or synthetic biology?
Nucleate is a global, student-run non-profit organization that facilitates the formation of new life science ventures [see stories in STAT, Endpoints, and the Boston Business Journal].
The Activator program provides education and support for academic trainees and investigators looking to spin out their research into a venture. It allows you to apply with an idea (you have a technology) or without one (join a team).
If you have an idea (i.e. you’re an Inventor), you can apply for either our Bio or Eco track:
- Bio Track: therapeutics, diagnostics, or tools
- Eco Track: food & agriculture, chemicals & energy, or consumer products
Don’t have an idea yet? You can join a team through the matching process as a scientific, business, or clinical contributor.
Nucleate offers:
- Completely free support – Nucleate never takes equity or charges fees for its programs.
- Mentorship from industry leaders – Receive guidance from experienced mentors.
- Comprehensive educational programming – Learn from the best in workshops and seminars.
- Investor introductions – Get connected with investors ready to support your breakthrough.
- No forced incorporation – Focus on your venture at your own pace.
Apply here by October 15, 2024.
To learn more, join us for a virtual info session on Tuesday, October 8th, at 5 PM. Register HERE.
Alternatively, join us at Nucleate NY 4.0 Kickoff: Thursday, October 10th, 5:30 PM at Biolabs at NYU Langone or one of our other events in NYC!
This event will feature an overview of Global Health Investment Corporation (GHIC), its relationship with the Biomedical Advanced Research and Development Authority (BARDA), and its funding opportunities. GHIC’s investments focus on strengthening global health security and addressing urgent global health challenges, including infectious disease and maternal and child health.
This event is hybrid. If you choose to attend virtually, a calendar invitation with the Zoom information will be sent to you a few days prior to the event. Please note that all 1:1 meetings with Dr. Devin Sok are in-person only. Location and time will be sent to each individual confirmed.
Agenda
10:30 - 11:30am | GHIC Presentation with Q&A
(Hybrid) Weill Cornell Medicine BioVenture eLab, 1157 York Ave or Zoom
12:00 - 2:00pm | Meetings with Dr. Devin Sok for inventors/startup companies
Weill Cornell Medicine campus, TBD
Join the leadership at Center for Technology Licensing (CTL) for the first of our Lab to Impact series, where we focus on intellectual property and guide you through the essential steps of the technology commercialization process. You will gain insights into the end-to-end process, from initial invention disclosure to IP protection, licensing, and ultimately, commercialization. Learn how CTL’s support can help you maximize the impact of your research by successfully navigating the complexities of the commercialization journey.
In this webinar, you will:
- Gain an initial understanding of the key elements of intellectual property law, including patents, trademarks, copyrights, and trade secrets. Learn how these protections serve as the foundation for securing the rights to your innovation.
- Learn how to develop compelling IP narratives that resonates with potential licensees, investors and collaborators.
Cornell Research & Innovation offers the virtual Innovation & Entrepreneurship Workshop Series to faculty, staff, post-docs, graduate and undergraduate students, and alumni at Cornell University to explore the potential of launching a business grounded in research. Questions? Contact crea@cornell.edu.
Calling pre-seed and seed innovators and entrepreneurs in Oncology, Cell & Gene Therapy, Cardiovascular, Immunology, Radiology, and Digital Health!
Do you have disruptive science but struggle to bring it to life in the entrepreneurial world? Bayer's passion is to enable and support standout healthcare innovation.
Take your innovation to new heights and join Bayer's Expert Mondays 2024, a series of knowledge exchange sessions to supercharge your startup’s growth.
Each one-hour Bayer's Expert Monday includes a live Q&A with respective Bayer Experts. You can stay for a Meet & Greet with Bayer Scouts and Scientific Finders. Please reserve 30 additional minutes in your schedule for the Meet & Greet after the Bayer Expert session.
These sessions are not intended for service providers, consultants, IT providers, etc. They are designed for drug developers and healthcare researchers seeking collaboration with big pharma and out-licensing opportunities later in their journey. Session recordings are NOT distributed afterward. Live attendance is necessary to get the most out of the expert sessions and network with the Bayer Pharma team.
The Sep 30 event features Dr. Anja Moews and Dr. Torsten Hertramp, Senior Directors BD&L, Due Diligence Center of Excellence. Reserve your spot here.
This event is part of an SBIR/STTR workshop series. It will feature an overview of NIH- and NCI-wide aspects of the federal SBIR/STTR programs and is open to WCM and non-WCM guests from various disciplines of science and medicine. Following the presentation, select inventors/companies will have the opportunity to meet one-on-one with Dr. Gregory Evans from the NCI.
Please indicate your interest in a 1:1 meeting in the registration form. You will not be scheduled for a 1:1 meeting if you do not select the option to request a 1:1 in the RSVP.
All 1:1 meetings will be in-person and take place on WCM campus (location and time will be sent to each individual confirmed for a 1:1 meeting in a calendar invite a few days prior to the event).
Led by the NSF I-Corps Hub: Interior Northeast (IN I-Corps), these free NSF I-Corps Regional Courses are designed for university-based STEM researchers and early-stage founders interested in evaluating the market potential of their technology and learning valuable entrepreneurial skills
In this month-long, virtual course (October 14 - November 14), researchers working on a deep tech innovation “get out of your comfort zone” and talk with customers (virtually) to identify the best product-market fit.
Applications will be reviewed on a rolling basis. Apply now. Application closes on Wednesday, September 18. Questions? Contact icorps@cornell.edu or visit www.in-icorps.org/regional-courses.
Are you an academic researcher, PI, professor, or graduate student with an interest in entrepreneurship or commercializing your technology? Join Osage University Partners on September 12 at 1pm ET, to learn about an incredible 2-year program.
- Activate is a two-year fellowship that provides early-stage hard-tech science entrepreneurs $100K in research funding, yearly stipends of $100K, intensive entrepreneurial training, mentorship, networking, and other benefits. Activate Fellows have raised over $2B in follow-on funding from leading public and private sources.
- Activate’s Cohort 2025 applications are open on September 4, and Activate will accept applications through October 23, 2024 at 5pm PT / 8pm ET.
Karrigan Turner and Rick Kempinski of Activate will join OUP's Nabil Ullah to talk about the program and answer questions live.
Register now.
